trending Market Intelligence /marketintelligence/en/news-insights/trending/jmgFHT24X1hpMhbjVygmEQ2 content esgSubNav
In This List

Bioptix CEO resigns; replacement named

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Bioptix CEO resigns; replacement named

Stephen Lundy resigned as CEO and director of Bioptix Inc., effective April 6.

Lundy's resignation was not the result of any disagreement with the company, any matter related to its operations, policies or practices, its management or the board.

Also effective April 6, Bioptix appointed Michael Beeghley as CEO to fill the vacancy created by Lundy's resignation. Beeghley currently serves as the chairman of the board.